Jeff Hooley

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Bioinformatics Analysis

Radical Prostatectomy

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Juniper A Scribner, Stuart W Hicks, Kerstin W Sinkevicius, Nicholas C Yoder, Gundo Diedrich, Jennifer G Brown, Jacquelynn Lucas, Megan E Fuller, Thomas Son, Anahita Dastur, Jeff Hooley, Christopher Espelin, Marian Themeles, Francine Z Chen, Ying Li, Michael Chiechi, Jenny Lee, Bhaswati Barat, Lusiana Widjaja, Sergey Gorlatov, James Tamura, Valentina Ciccarone, Olga Ab, Kerry A McEachem, Scott Koenig, Eric H Westin, Paul A Moore, Thomas Chittenden, Richard J Gregory, Ezio Bonvini, Deryk Loo
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors. Molecular cancer therapeutics 21 (7) (2022)
Juniper A Scribner, Jennifer G Brown, Thomas Son, Michael Chiechi, Pam Li, Sharad Sharma, Hua Li, Anushka De Costa, Ying Li, Yan Chen, Ann Easton, Nicholas C Yee-Toy, Francine Z Chen, Sergey Gorlatov, Bhaswati Barat, Ling Huang, Christina R Wolff, Jeff Hooley, Tim E Hotaling, Timur Gaynutdinov, Valentina Ciccarone, James Tamura, Scott Koenig, Paul A Moore, Ezio Bonvini, Deryk Loo
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer. Molecular cancer therapeutics 19 (11) (2020)